Study identifies unique underlying molecular factors driving melanoma development

Source: The OSUCCC, June 2022

COLUMBUS, Ohio – A new study reveals important molecular information that could help scientists develop more effective treatment and prevention strategies for a difficult-to-treat form of melanoma skin cancer.

In this new report, Christin Burd who serves an associate professor of molecular genetics in The Ohio State University College of Arts and Sciences, Department of Molecular Genetics and a member of the OSUCCC – James Molecular Carcinogenesis and Chemoprevention Program.

“NRAS-mutant cancers are challenging to treat because effective therapies beyond immunotherapy don’t exist yet,” said Burd. “Each cancer type seems to prefer a specific ‘flavor’ of mutant NRAS, and it has not been clear why this is.”

READ THE ORIGINAL FULL ARTICLE